Progesterone receptor loss identifies hormone receptor-positive and HER2-negative breast cancer subgroups at higher risk of relapse: a retrospective cohort study.

about

Cadherin-11 expression is upregulated in invasive human breast cancer.

P2860

Q37581797-E978C29B-F18C-4EEB-A3A3-E9C5C10F62B6

P2860

Progesterone receptor loss identifies hormone receptor-positive and HER2-negative breast cancer subgroups at higher risk of relapse: a retrospective cohort study.

Item

http://www.wikidata.org/entity/Q36729240

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Progesterone receptor loss ide ...... a retrospective cohort study.

@ast

Progesterone receptor loss ide ...... a retrospective cohort study.

@en

type

Item

label

Progesterone receptor loss ide ...... a retrospective cohort study.

@ast

Progesterone receptor loss ide ...... a retrospective cohort study.

@en

prefLabel

Progesterone receptor loss ide ...... a retrospective cohort study.

@ast

Progesterone receptor loss ide ...... a retrospective cohort study.

@en

P1476

Progesterone receptor loss ide ...... a retrospective cohort study.

@en

P2093

Feng-Yan Li

http://www.w3.org/2001/XMLSchema#string

Huan-Xin Lin

http://www.w3.org/2001/XMLSchema#string

Jia-Yuan Sun

http://www.w3.org/2001/XMLSchema#string

San-Gang Wu

http://www.w3.org/2001/XMLSchema#string

Zhen-Yu He

http://www.w3.org/2001/XMLSchema#string

P2860

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

Tailoring therapies--improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015

Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

Progesterone receptor status and Ki-67 index may predict early relapse in luminal B/HER2 negative breast cancer patients: a retrospective study.

Poor prognosis of single hormone receptor- positive breast cancer: similar outcome as triple-negative breast cancer.

A review of an unfavorable subset of breast cancer: estrogen receptor positive progesterone receptor negative

Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients.

Biology of progesterone receptor loss in breast cancer and its implications for endocrine therapy.

Prognostic significance of progesterone receptor-positive tumor cells within immunohistochemically defined luminal A breast cancer.

Breast cancer subtypes and response to docetaxel in node-positive breast cancer: use of an immunohistochemical definition in the BCIRG 001 trial.

P304

1707-1713

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/OTT.S98666

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-03-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27051305

http://www.w3.org/2001/XMLSchema#string

P932

4807933

http://www.w3.org/2001/XMLSchema#string

Progesterone receptor loss identifies hormone receptor-positive and HER2-negative breast cancer subgroups at higher risk of relapse: a retrospective cohort study.

about

P2860

P2860

Progesterone receptor loss identifies hormone receptor-positive and HER2-negative breast cancer subgroups at higher risk of relapse: a retrospective cohort study.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P698

P932